Needham Remains a Buy on Phathom Pharmaceuticals (PHAT)
Needham analyst Joseph Stringer maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today and set a price target of ...
Phathom Pharmaceuticals Announces Leadership Succession
We are excited to welcome Steve to Phathom during this important growth period for our Company,” said Michael Cola, Chairman of Phathom. “Steve is an accomplished biopharmaceutical leader with a ...